drugset / Trial / NCT02081703
Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The objectives of this study are to evaluate the safety and analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection at two dose/volume levels.
Timeline
- Start
- 2014-05
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivoligide | Unknown | 660 mg | Intrathecal |
| Subject | Brivoligide | Unknown | 1100 mg | Intrathecal |
Indications
No indication recorded.